Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Leukemia|July 25, 2024
The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasmsLingxu Jiang, Yudi Zhang, Jiejing Qian, et al.British Journal of Haematology|November 8, 2023
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemiaNianci Chen, Jiajia Pan, Yile Zhou, et al.Journal of Cancer Research and Clinical Oncology|January 11, 2022
Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromesLingxu Jiang, Li Ye, Liya Ma, et al.Experimental Hematology & Oncology|January 29, 2025
EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromesQi Zhang, Yingwan Luo, Li Ye, et al.Journal of Cancer Research and Clinical Oncology|January 22, 2017
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy aloneLi Ye, Yanling Ren, Xinping Zhou, et al.Haematologica|November 20, 2025
Decitabine plus all-trans retinoic acid versus decitabine monotherapy for myelodysplastic syndromes with excess blasts: a multicenter, randomized controlled trialXinping Zhou, Yanjuan Lin, Yan Gao, et al.Haematologica|June 12, 2025
Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trialChen Mei, Gaixiang Xu, Cuiping Zheng, et al.The Lancet. Haematology|May 5, 2022
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trialHuafeng Wang, Liping Mao, Min Yang, et al.BMC Infectious Diseases|October 11, 2024
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in ChinaLi Ye, Ye Yang, Xuewu Zhang, et al.Experimental Hematology & Oncology|March 30, 2023
The clinical impact of IKZF1 mutation in acute myeloid leukemiaXiang Zhang, Aijie Huang, Lixia Liu, et al.Pageof 4